A. L. Bloom 2026-11-05
A. L. Bloom was a coagulation researcher who, with J. C. Giddings, investigated how activated Factor V promotes production of thrombin. Their 1975 study reconstructed the reaction using purified coagulation factors.[ref]
Factor-V activation by thrombin and its role in prothrombin conversion by J. C. Giddings and A. L. Bloom. Byline and Abstract: purified-factor experiments
Pretreating Factor V with trace amounts of thrombin increased the rate and yield of subsequent thrombin generation from prothrombin. The finding supported a positive feedback mechanism: product formation could enhance further product formation by activating a cofactor.[ref]
Factor V 2026-11-05
Factor V is a coagulation factor whose activated form, factor Va, is a protein cofactor in the prothrombinase complex. Limited proteolysis, including cleavage by thrombin, converts Factor V into the more active cofactor. In the assembled complex, factor Xa performs the cleavage of prothrombin to thrombin; factor Va helps the reaction occur efficiently on a phospholipid surface in the presence of calcium ions.[ref]
Factor-V activation by thrombin and its role in prothrombin conversion by J. C. Giddings and A. L. Bloom. Abstract: thrombin pretreatment and reconstitution from purified components
The distinction between precursor and activated cofactor matters experimentally. Investigators mixed purified coagulation factors, separated the products by gel chromatography, and identified components with specific antibodies. Pretreating Factor V with small amounts of thrombin increased the rate and yield of subsequent thrombin generation. A little product could therefore promote production of more product: a positive feedback mechanism within coagulation.[ref]
Factor-V activation by thrombin and its role in prothrombin conversion by J. C. Giddings and A. L. Bloom. Abstract: column fractions, immunological analysis, and kinetic experiments
Factor Va 2026-11-05
Factor Va is the activated form of Factor V that serves as a protein cofactor for factor Xa during prothrombin activation. In the membrane-associated complex, factor Xa supplies the proteolytic catalyst while factor Va helps organize efficient conversion to thrombin.[ref]
Crystal Structure of Prothrombin Reveals Conformational Flexibility and Mechanism of Activation by Nicola Pozzi and others. Introduction: prothrombinase components and substrate interactions
The cofactor's effect can be measured by reconstituting the reaction from purified components. In a bovine study with one defined phospholipid mixture, adding factor Va reduced the apparent Michaelis constant for prothrombin from to . Other vesicle compositions gave different relationships between binding and apparent kinetics.[ref]
Kinetic studies of prothrombin activation: effect of factor Va and phospholipids on formation of the enzyme-substrate complex by J. L. van Rijn and others. Abstract: vesicles with 20 mole percent phosphatidylglycerol and 80 mole percent phosphatidylcholine
The ratio describes the change in that apparent kinetic parameter. It does not imply that every reaction rate rises 55-fold: the observed rate also depends on substrate abundance and the limiting rate. The example shows how a noncatalytic protein can strongly regulate an enzyme reaction by participating in its molecular assembly.
Factor X 2026-11-05
Factor X is the zymogen of factor Xa, a serine protease involved in coagulation. Limited proteolysis activates Factor X; the resulting factor Xa cleaves prothrombin to form thrombin. Efficient membrane-associated activation uses the prothrombinase complex, containing factor Xa, factor Va, calcium ions and phospholipids.[ref]
Coagulation factor Xa EC 3.4.21.6 in IUBMB Enzyme Nomenclature. Accepted name, reaction and comments: precursor activation and prothrombin conversion
The human protein contains a heavy chain and a light chain joined by disulfide bonds. This chain structure and activation are different distinctions: having two linked chains does not by itself mean that the zymogen has become factor Xa.[ref]
Coagulation factor Xa EC 3.4.21.6 in IUBMB Enzyme Nomenclature. Comments: precursor processing and limited proteolysis
For example, a preparation can contain abundant Factor X yet require an activating cleavage before efficiently supporting thrombin production. Conversely, detecting factor Xa activity reports an activated enzyme, not merely the presence of its precursor. Purified-component experiments establish the downstream reaction independently of a whole blood clot, allowing the catalytic role of factor Xa to be distinguished from the assisting role of factor Va.[ref]
Factor-V activation by thrombin and its role in prothrombin conversion by J. C. Giddings and A. L. Bloom. Abstract: prothrombin conversion by the reconstituted complex
Factor Xa 2026-11-05
Factor Xa is the activated serine protease derived from Factor X by limited proteolysis. It catalyses cleavage of prothrombin to generate thrombin, an important activation step in coagulation. Efficient conversion is organized by factor Va, calcium and phospholipids.[ref]
Coagulation factor Xa EC 3.4.21.6 in IUBMB Enzyme Nomenclature. Reaction and comments: precursor, activation and prothrombin conversion
Purified-component experiments varied the phospholipid surface and the presence of factor Va, showing that apparent kinetic parameters depend on how the components assemble. The same amount of factor Xa can therefore produce different reaction rates in different surroundings.[ref]
For an invented catalytic accounting example, 1 nmol of active factor Xa generates 100 nmol of activated product during an interval. That is 100 product molecules per initial enzyme molecule, demonstrating catalytic reuse rather than one-to-one consumption. The value is not a measured turnover number: a true rate constant requires a specified time, substrate availability and activation pathway.
J. L. van Rijn 2026-11-05
J. L. van Rijn is the first author of a 1984 study of how membrane composition and an accessory protein affect activation of prothrombin. The investigators varied phospholipid concentration and composition, with and without factor Va, and measured the action of factor Xa on bovine prothrombin. This tested an enzyme in a membrane-associated reaction system rather than assuming that its behavior in solution determines the whole process.[ref]
For vesicles containing 20 mole percent phosphatidylglycerol and 80 mole percent phosphatidylcholine, the reported apparent Michaelis constant for prothrombin was 0.04 micromolar with factor Va, compared with 2.2 micromolar without it. The ratio is . That comparison shows the scale of the change in an apparent kinetic parameter; it is not a claim that the reaction rate increases 55-fold at every substrate concentration. The experiment illustrates how a surface and an accessory protein can change the effective behavior of a biochemical reaction.[ref]
Phosphatidylglycerol 2026-11-05
Phosphatidylglycerol is a glycerophospholipid whose usual membrane form has two fatty acid chains attached by ester linkages to a glycerol backbone, with a phosphate linking that backbone to a second glycerol. Its name describes a family: the fatty acid chains can vary. In the deprotonated form, the phosphate-containing head carries a net negative electric charge.[ref]
Phosphatidylglycerol in ChEBI. CHEBI:17517, structure and definition; CHEBI:60523, conjugate-base charge
The two chains and the charged head give phosphatidylglycerol different interactions with water and membrane-bound proteins. A useful controlled example comes from enzyme kinetics: J. L. van Rijn and colleagues activated bovine prothrombin using factor Xa on liposomes containing 20% phosphatidylglycerol and 80% phosphatidylcholine by mole fraction. Adding factor Va changed the apparent Michaelis constant from to . This compares the same stated membrane composition with and without a protein cofactor; it does not imply that adding phosphatidylglycerol alone universally multiplies the reaction rate by 55.[ref]
Prothrombin 2026-11-05
Prothrombin is the zymogen, or inactive precursor, from which the protease thrombin is generated during coagulation. Controlled proteolysis converts a circulating precursor into an active enzyme. factor Xa catalyses activation, with factor Va and a phospholipid surface greatly affecting the reaction's efficiency.[ref]
A purified bovine system varied both vesicle composition and the presence of factor Va. With one defined mixture, the apparent Michaelis constant for prothrombin was without factor Va and with it, a 55-fold difference. The result connects the enzyme reaction to assembly on a phospholipid surface, rather than treating the surrounding lipids as inert solvent.[ref]
Kinetic studies of prothrombin activation: effect of factor Va and phospholipids on formation of the enzyme-substrate complex by J. L. van Rijn and others. Abstract: vesicles containing 20 mole percent phosphatidylglycerol and 80 mole percent phosphatidylcholine
An apparent Michaelis constant in this assembled system summarizes several interacting steps; it need not equal a single molecular binding constant. In an activation assay, detecting the newly generated thrombin's activity also differs from merely measuring how much prothrombin remains.
Prothrombinase complex 2026-11-05
The prothrombinase complex is a membrane-associated assembly that converts prothrombin into thrombin. Its catalytic enzyme is factor Xa, assisted by the protein cofactor factor Va, calcium ions, and a phospholipid surface. The protease and its assembled reaction system are distinct: factor Va helps organize efficient prothrombin conversion without replacing the catalytic role of factor Xa.[ref]
Coagulation factor Xa EC 3.4.21.6 in IUBMB Enzyme Nomenclature. Comments; factor Xa, factor Va, calcium and phospholipids in prothrombin conversion
Experiments in 1975 combined purified coagulation components and used chromatography to separate the material formed. Tests with specific antibodies helped identify the factors in the collected fractions, and kinetic measurements established that the assembled preparation converted purified prothrombin into thrombin. These supplied different kinds of evidence: association of components, and catalytic activity.[ref]
Factor-V activation by thrombin and its role in prothrombin conversion by J. C. Giddings and A. L. Bloom. British Journal of Haematology 29, pp. 349–364; abstract, Sephadex fractionation, antibody analysis and purified-factor kinetics
Pretreating Factor V with trace amounts of thrombin increased the subsequent rate and yield of thrombin production. This illustrates positive feedback: a product of the reaction helps activate a component that promotes further product formation. A single observed rate increase would not establish complex composition; the fractionation and identification experiments addressed that separate question.[ref]
Factor-V activation by thrombin and its role in prothrombin conversion by J. C. Giddings and A. L. Bloom. Abstract; thrombin pretreatment of factor V and subsequent thrombin generation